Clinical trial complexity has significantly increased in the past decade. How can the industry adapt and innovate to remain ...

Anixa Biosciences (ANIX) announced that it, along with its partner Moffitt Cancer Center, has received approval for an amendment to the ...

In this video interview, Dominique Demolle, CEO of Cognivia, highlights how patient non-adherence could increase trial ...

Oncology studies present unique challenges when it comes to participant treatment, resupply, and study management.

Amendment expands the potential benefits of CAR-T therapy allowing a second dose and includes more ovarian cancer histologies SAN JOSE, Calif., Feb. 18, 2025 /PRNewswire/ ...

Drug development is an expensive and high-risk process. The median cost per approved drug can reach up to $2.8 billion, ...

Gibson, Dunn & Crutcher has filed multiple suits on behalf or organizations that provide legal services to immigrants, and ...

The American Journal of Managed Care provides insights into the latest news and research in managed care across multimedia ...

Patients with psoriasis, psoriatic arthritis, and axial spondylarthritis using ixekizumab have a low incidence rate of cerebro-cardiovascular events.

Q4 2024 Earnings Call Transcript February 20, 2025 Prothena Corporation plc misses on earnings expectations. Reported EPS is ...

A minority of studies used the standard three-point MACE endpoint, and many tweaked their endpoints along the way.

"The launch of PeachesRx is the natural next step in Mangoceuticals' expansion as we continue to redefine direct-to-consumer ...